Answers are grounded in this paper and cite their sources.
Artificial intelligence shows considerable promise for clinical decision-making. However, developing models that generalize across heterogeneous real-world settings while maintaining complex diagnostic reasoning remains challenging. There is a need for high-quality datasets that capture long-tail, multi-stage clinical reasoning processes to support robust AI deployment in clinical practice. We introduce RareMed-Dialogue, a high-quality, auditable Chinese multi-turn clinical dialogue dataset constructed from 10,114 authentic difficult, rare, and complex cases representing the clinical long tail. These cases focus on high-risk clinical scenarios characterized by structural complexity, multidisciplinary coordination, and iterative diagnostic inquiry. Each clinical case was transformed into a rule-based template covering eight key stages of the diagnostic and therapeutic workflow. Multi-turn dialogues were then generated under the guidance of multidisciplinary expert input, followed by human verification and augmentation using large language models. To evaluate dataset quality, we developed a dedicated evaluation framework incorporating two novel metrics: Dialogue-chain Integrity (DCI) and Stage Accuracy (SA), designed to assess coherence and correctness across multi-turn clinical reasoning processes. RareMed-Dialogue demonstrates three key properties: (i) multi-turn, dialogue-driven reconstruction of diagnostic and therapeutic workflows; (ii) integration of multi-stage clinical tasks within a unified conversational structure; and (iii) high clinical fidelity with explicit interpretability. The dataset faithfully reproduces complex diagnostic processes requiring iterative inquiry and multidisciplinary collaboration in long-tail clinical scenarios. RareMed-Dialogue provides a structured resource for training and benchmarking artificial intelligence systems on complex clinical reasoning tasks. Further external validation is needed to determine its generalizability to real-world clinical settings. Data access and usage details are provided in the Supplementary Materials.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: